HealthCare Market Analysis

The global  medical device testing services market  size is expected to reach USD 13.4 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 11.5% during the forecast period. Increasing spending in preclinical phase of medical devices coupled with growing outsourcing rate is anticipated to help the market gain significant traction. Surging demand for in-vitro test is also projected to fuel demand for testing services as many CROs are developing novel in-vitro methods to replace traditional in-vivo methods, which require animal testing. Improvements in procedures for development and standardization of novel in vitro test methods, particularly for sensitization, cytotoxicity, and irritation, are also working in favor of the market. There has been a significant increase in preclinical spending for both pharmaceutical and medical devices. This trend is estimated to contribute to the demand for testing services by medical...

Global  sleep apnea devices market  is expected to reach over USD 7,991.2 Million by 2022 according to a new report by Grand View Research Inc. Technological advancements pertaining to the development of novel PAP devices and PAP masks which are portable, highly efficient and are easy to use is expected to positively reinforce market growth.  The U.S. has one of the highest numbers of people suffering from sleep apnea. In 2014, as per the National Sleep Foundation, more than 18 million adults across different age groups have sleep apnea and nearly two to three percent cases are related to childhood OSA and the numbers are much higher in children with habitual snoring. The increasing prevalence of sleep apnea in co-morbidities and subsequent increase in the diagnosis and treatment rate is a major factor expected to boost the product sales over the next seven years. The most common conditions associated with this disorder include respiratory diseases, str...

The global  research antibodies market  size is expected to reach USD 4.30 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.1% during the forecast period. The market is predominantly driven by growing number of R&D collaborations among various public and private organizations to promote technical advancements in product development activities and disease progression studies. Consistent recommendations and guidelines issued by regulatory organizations for laboratories to facilitate generation of accurate results and ensure high-quality standards are slated to enhance adoption of research antibodies over the coming years. For instance, in May 2016, the International Society for Stem Cell Research issued revised guidelines for cell-based therapies. The revised guidelines were issued with a focus to improve overall efficiency and quality of preclinical studies. In addition, prominent market players are entering in...